home / stock / lvtx / lvtx news

LVTX News and Press, LAVA Therapeutics N.V.

Stock Information
Company Name: LAVA Therapeutics N.V.
Stock Symbol: LVTX
Market: NASDAQ
Website: lavatherapeutics.com
Menu
LVTX LVTX Quote LVTX Short LVTX News LVTX Articles LVTX Message Board
Get LVTX Alerts

News, Short Squeeze, Breakout and More Instantly...
LVTX - LAVA Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference

UTRECHT, The Netherlands and PHILADELPHIA, June 20, 2024 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (NASDAQ: LVTX, “LAVA”), a clinical-stage immuno-oncology company focused on developing its proprietary Gammabody ® platform of bispecific gamma delta T cell eng...
LVTX - LAVA Therapeutics to Participate in the Jefferies Global Healthcare Conference

UTRECHT, The Netherlands and PHILADELPHIA, May 30, 2024 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (NASDAQ: LVTX, “LAVA,” or “Company”), a clinical-stage immuno-oncology company focused on developing its proprietary Gammabody® platform of bispecific gamm...

LVTX - LAVA Therapeutics GAAP EPS of -$0.02 beats by $0.20, revenue of $6.99M beats by $3.49M

2024-05-21 07:37:51 ET More on LAVA Therapeutics Lava gets $7M from Pfizer as trial for cancer drug advances Seeking Alpha’s Quant Rating on LAVA Therapeutics Historical earnings data for LAVA Therapeutics Financial information for LAVA Therapeutics ...

LVTX - LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results

LAVA-1207 dose escalation progressing in Phase 1/2a trial in prostate cancer, with pembrolizumab combination expected to begin in Q2 2024 Received $7.0 million clinical development milestone from Pfizer for PF-08046052 (formerly LAVA-1223) in Phase 1 LAVA-1266 on track for Q2 2024 IND sub...
LVTX - LAVA Therapeutics to Participate in the Citizens JMP Life Sciences Conference

UTRECHT, The Netherlands and PHILADELPHIA, May 06, 2024 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (NASDAQ: LVTX, “LAVA,” or “Company”), a clinical-stage immuno-oncology company focused on developing its proprietary Gammabody® platform of bispecific gamm...

LVTX - LAVA Therapeutics GAAP EPS of -$0.24 beats by $0.18

2024-03-21 12:17:05 ET More on LAVA Therapeutics Lava gets $7M from Pfizer as trial for cancer drug advances LAVA stock rises on clinical trial collaboration with Merck Seeking Alpha’s Quant Rating on LAVA Therapeutics Historical earnings data for LAVA...

LVTX - Biotech stocks to watch

2024-03-20 10:20:00 ET March 20, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech/Life Sciences sector. The newest biotech companies are involved in immuno-oncology, ...
LVTX - LAVA Provides Business Updates and Reports Fourth Quarter and Year-End Financial Results

LAVA-1207 progressing in Phase 1/2a study, with pembrolizumab combination expected to begin in Q2 2024 In March 2024, Pfizer paid LAVA $7 million for achieving a clinical milestone for EGFRd2 (PF-08046052/formerly LAVA-1223) LAVA 1266 tracking to Q2 2024 IND submission...

LVTX - Lava gets $7M from Pfizer as trial for cancer drug advances

2024-03-05 10:28:49 ET More on LAVA Therapeutics LAVA stock rises on clinical trial collaboration with Merck Seeking Alpha’s Quant Rating on LAVA Therapeutics Historical earnings data for LAVA Therapeutics Financial information for LAVA Therapeutics ...

LVTX - US Companies Moving the Markets, Morning edition
Tue, Mar 05, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 61.6% to $0.143 on volume of 387,468,585 shares Fisker Inc. Class A (FSR) fell 8.5% to $0.4415 on volume of 205,557,321 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 3.0% to $3.22 on vol...
Next 10